Monovalent XBB.1.5 booster vaccination induces a broad spectrum of SARS-CoV-2 neutralizing antibodies

Monovalent XBB.1.5 booster vaccination induces a broad spectrum of SARS-CoV-2 neutralizing antibodies

Saved in:

Bibliographic Details
Main Authors:	Nan Huo, Shipo Wu, Yudong Wang, Busen Wang, Zhe Zhang, Jinlong Zhang, Xiaohong Song, Lihua Hou, Wei Chen
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Emerging Microbes and Infections
Subjects:	SARS-CoV-2 Omicron variant XBB.1.5 booster vaccine neutralizing antibody
Online Access:	https://www.tandfonline.com/doi/10.1080/22221751.2023.2286260
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
by: Danyi Ao, et al.
Published: (2023-04-01)

Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement
by: Elena Criscuolo, et al.
Published: (2024-11-01)

Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?
by: Jinghao Nicholas Ngiam, et al.
Published: (2024-12-01)

Neutralizing antibody test supports booster strategy for young individuals after SARS-CoV-2 Omicron breakthrough
by: Yichuan Yao, et al.
Published: (2025-01-01)

Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients
by: Philippa von der Schulenburg, et al.
Published: (2024-12-01)

Dynamics of SARS-CoV-2 variants during the XBB wave in the Republic of Korea
by: Jin Sun No, et al.
Published: (2024-12-01)

A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children
by: Frances Priddy, et al.
Published: (2024-12-01)

Determination of T cell response against XBB variants in adults who received either monovalent wild-type inactivated whole virus or mRNA vaccine or bivalent WT/BA.4-5 COVID-19 mRNA vaccine as the additional booster
by: Yun Sang Tang, et al.
Published: (2024-12-01)

Comparison of immune responses to SARS-CoV-2 spike following Omicron infection or Omicron BA.4/5 vaccination in kidney transplant recipients
by: Inga Tometten, et al.
Published: (2025-01-01)

Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies
by: Abundio Balgos, et al.
Published: (2024-12-01)

COVID-19 Vaccine Booster Dose Fails to Enhance Antibody Response to Omicron Variant in Reinfected Healthcare Workers
by: Leire Fernández-Ciriza, et al.
Published: (2025-01-01)

Exploring pyrazolines as potential inhibitors of NSP3-macrodomain of SARS-CoV-2: synthesis and in silico analysis
by: Rekha Joshi, et al.
Published: (2025-01-01)

Immune evasion after SARS-CoV-2 Omicron BA.5 and XBB.1.9 endemic observed from Guangdong Province, China from 2022 to 2023
by: Huan Zhang, et al.
Published: (2024-11-01)

Neutralizing Antibody-Mediated Protection from Prior Delta Variant Infection Against Omicron BA.5 Sub-Lineage Reinfection One Year Later: A Prospective Cohort Study
by: Shihan Zhang, et al.
Published: (2024-10-01)

Single-cell transcriptome atlas of peripheral immune features to Omicron breakthrough infection under booster vaccination strategies
by: Yuwei Zhang, et al.
Published: (2025-01-01)

Structural insight into broadening SARS-CoV-2 neutralization by an antibody cocktail harbouring both NTD and RBD potent antibodies
by: Wenling Jiang, et al.
Published: (2024-12-01)

High SARS-CoV-2 antibody levels after three consecutive BNT162b2 booster vaccine doses in nursing home residents
by: Marloes I Hofstee, et al.
Published: (2025-01-01)

A descriptive review on the real-world impact of Moderna, Inc. COVID-19 vaccines
by: Mary Bausch-Jurken, et al.
Published: (2024-12-01)

STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease
by: Simon Woelfel, et al.
Published: (2024-10-01)

Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
by: Ching-Wen Hou, et al.
Published: (2025-01-01)

Immunogenicity of the CoronaVac vaccine in children: a real-world study
by: Wbeimar Aguilar-Jimenez, et al.
Published: (2024-12-01)

Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants
by: Léa Dépéry, et al.
Published: (2025-01-01)

Development and application of an uncapped mRNA platform
by: Xiaodi Zheng, et al.
Published: (2025-12-01)

Clinical Characteristics and Outcomes of Hospitalized COVID-19 Patients with Different Variants of SARS-CoV-2 in a Tertiary Care Hospital, Thailand
by: Kitchawan Hengkrawit, et al.
Published: (2024-11-01)

Strategi Komunikasi Pemerintah Provinsi di Indonesia Dalam Program Vaksinasi Booster Melalui X
by: Yohanes Thianika Budiarsa, et al.
Published: (2024-12-01)

Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan
by: Chanroth Chhoung, et al.
Published: (2024-11-01)

Nationwide seroprevalence of SARS-CoV-2 Delta variant and five Omicron sublineages in companion cats and dogs in the USA: insights into their role in COVID-19 epidemiology
by: Subarna Barua, et al.
Published: (2025-12-01)

Comparative immunogenicity of monovalent and bivalent adenovirus vaccines carrying spikes of early and late SARS-CoV-2 variants
by: Hengchun Li, et al.
Published: (2024-12-01)

Modelling the Potential Public Health Impact of Different COVID-19 Vaccination Strategies with an Adapted Vaccine in Singapore
by: Karan Thakkar, et al.
Published: (2024-12-01)

Strategic Health Diplomacy: An Indonesia’s Approach in Securing COVID-19 Booster Vaccine Supplies
by: Deasy Silvya Sari, et al.
Published: (2024-06-01)

Comparison of antibody responses of heterologous and homologous Covid-19 booster vaccination: an observational study
by: Nayab Batool Rizvi, et al.
Published: (2024-11-01)

Boosters in academic discourse: contrastive analysis concerning their use in theses from the fields of social sciences and natural sciences
by: Francisco J. Álvarez-Gil, et al.
Published: (2024-11-01)

Whole genome sequencing analysis of SARS-CoV-2 Omicron variant isolated ‎from Egypt‎
by: Hanaa Ahmed, et al.
Published: (2024-08-01)

Preparation and application of porcine broadly neutralizing monoclonal antibodies in an immunoassay for efficiently detecting neutralizing antibodies against foot-and-mouth disease virus serotype O
by: Yimei Cao, et al.
Published: (2025-02-01)

Clinical Summary of 186 Cases of Orbital Autologous Fat Injection Transplantation Safely Implemented by Boosters
by: LIU Ping, et al.
Published: (2024-10-01)

Evaluating COVID-19 Vaccine Efficacy Using Kaplan–Meier Survival Analysis
by: Waleed Hilal, et al.
Published: (2024-10-01)

Mushroom β-glucan and polyphenol formulations as natural immunity boosters and balancers: nature of the application
by: Maja Kozarski, et al.
Published: (2023-03-01)

Effectiveness of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2.2 Infection in Beijing, China, 2022: A Cohabitation Retrospective Cohort Study
by: Shuaibing Dong, et al.
Published: (2024-12-01)

Insights into Omicron: Genomic Characterization and Inpatient Risk Assessment at Single Tertiary Hospital in Indonesia
by: Turbawaty DK, et al.
Published: (2025-01-01)

Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China
by: Chao-Chao Qiu, et al.
Published: (2025-02-01)